Fosavance



Indications and Reactions:

Role Indications Reactions
Primary
Osteoporosis 36.5%
Product Used For Unknown Indication 21.9%
Hypertension 6.2%
Rheumatoid Arthritis 5.6%
Osteoporosis Prophylaxis 4.5%
Osteoporosis Postmenopausal 3.4%
Non-hodgkin's Lymphoma 2.8%
Osteopenia 2.8%
Atrial Fibrillation 2.2%
Blood Pressure 1.7%
Osteogenesis Imperfecta 1.7%
Respiratory Failure 1.7%
Arthralgia 1.1%
Back Pain 1.1%
Blood Cholesterol Increased 1.1%
Bone Disorder 1.1%
Breast Cancer 1.1%
Compression Fracture 1.1%
Deep Vein Thrombosis 1.1%
Depression 1.1%
Osteonecrosis 15.3%
Femur Fracture 10.2%
Osteonecrosis Of Jaw 8.5%
Weight Decreased 8.5%
Myalgia 5.1%
Pancreatitis Acute 5.1%
Pathological Fracture 5.1%
Anaphylactic Shock 3.4%
Bone Fissure 3.4%
Breast Cancer Female 3.4%
Cardiac Arrest 3.4%
Death 3.4%
Foot Fracture 3.4%
Hypercalcaemia 3.4%
Malaise 3.4%
Neoplasm Malignant 3.4%
Oesophagitis Ulcerative 3.4%
Pain 3.4%
Thrombocytopenia 3.4%
Anaemia 1.7%
Secondary
Product Used For Unknown Indication 35.9%
Osteoporosis 20.3%
Drug Use For Unknown Indication 10.4%
Rheumatoid Arthritis 8.7%
Hypertension 3.9%
Non-hodgkin's Lymphoma 3.9%
Atrial Fibrillation 2.2%
Essential Hypertension 1.7%
Breast Cancer 1.3%
Deep Vein Thrombosis 1.3%
Depression 1.3%
Hypercholesterolaemia 1.3%
Osteopenia 1.3%
Pain 1.3%
Arrhythmia 0.9%
Back Pain 0.9%
Compression Fracture 0.9%
Dementia 0.9%
Diarrhoea 0.9%
Gastric Ulcer 0.9%
Osteonecrosis 11.8%
Sepsis 9.8%
Rhabdomyolysis 7.8%
Tooth Abscess 7.8%
Transaminases Increased 7.8%
Osteonecrosis Of Jaw 5.9%
Renal Cyst 5.9%
Renal Failure Acute 5.9%
Femur Fracture 3.9%
Malaise 3.9%
Pathological Fracture 3.9%
Somnolence 3.9%
Thrombosis 3.9%
Tooth Extraction 3.9%
Upper Limb Fracture 3.9%
Alopecia 2.0%
Constipation 2.0%
Device Failure 2.0%
Fall 2.0%
Gastrooesophageal Reflux Disease 2.0%
Concomitant
Rheumatoid Arthritis 23.6%
Drug Use For Unknown Indication 19.1%
Product Used For Unknown Indication 16.9%
Osteoporosis 10.6%
Hypertension 7.8%
Pain 4.3%
Depression 2.4%
Hiv Infection 2.1%
Ankylosing Spondylitis 2.0%
Diabetes Mellitus 1.4%
Prophylaxis 1.3%
Psoriasis 1.2%
Breast Cancer 1.0%
Coronary Artery Disease 1.0%
Thrombosis Prophylaxis 1.0%
Urinary Tract Infection 1.0%
Atrial Fibrillation 0.9%
Premedication 0.9%
Dyslipidaemia 0.8%
Asthma 0.7%
Pulmonary Embolism 10.4%
Tachycardia 9.6%
Pyrexia 6.4%
Vomiting 6.4%
Osteonecrosis 5.6%
Death 4.8%
Drug Interaction 4.8%
Renal Failure Acute 4.8%
Syncope 4.8%
Tibia Fracture 4.8%
Weight Decreased 4.8%
Weight Increased 4.8%
Disseminated Tuberculosis 4.0%
Pneumonia 4.0%
Psoriasis 4.0%
Diarrhoea 3.2%
Dyspnoea 3.2%
Fall 3.2%
Myocardial Infarction 3.2%
Pseudomembranous Colitis 3.2%
Interacting
Product Used For Unknown Indication 57.1%
Back Pain 14.3%
Osteoporotic Fracture 14.3%
Parkinson's Disease 14.3%
Sleep Disorder 66.7%
Osteonecrosis Of Jaw 33.3%